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Abstract
Objective: The objective of this update article is to report structural and functional neuroimaging studies exploring the potential role 
of cerebellum in the pathophysiology of psychiatric disorders. Method: A non-systematic literature review was conducted by means of 
Medline using the following terms as a parameter: “cerebellum”, “cerebellar vermis”, “schizophrenia”, “bipolar disorder”, “depression”, “anxiety 
disorders”, “dementia” and “attention deficit hyperactivity disorder”. The electronic search was done up to April 2008. Discussion: Structural 
and functional cerebellar abnormalities have been reported in many psychiatric disorders, namely schizophrenia, bipolar disorder, major 
depressive disorder, anxiety disorders, dementia and attention deficit hyperactivity disorder. Structural magnetic resonance imaging 
studies have reported smaller total cerebellar and vermal volumes in schizophrenia, mood disorders and attention deficit hyperactivity 
disorder. Functional magnetic resonance imaging studies using cognitive paradigms have shown alterations in cerebellar activity in 
schizophrenia, anxiety disorders and attention deficit hyperactivity disorder. In dementia, the cerebellum is affected in later stages of the 
disease. Conclusion: Contrasting with early theories, cerebellum appears to play a major role in different brain functions other than balance 
and motor control, including emotional regulation and cognition. Future studies are clearly needed to further elucidate the role of cerebellum 
in both normal and pathological behavior, mood regulation, and cognitive functioning.
Descriptors: Cerebellum; Schizophrenia; Mood disorders; Anxiety disorders; Dementia 
Resumo
Objetivo: Este artigo de atualização  tem como objetivo avaliar estudos em neuroimagem estrutural e funcional a fim de explorar o 
papel do cerebelo na patofisiologia dos transtornos psiquiátricos. Método: Uma revisão não sistemática foi realizada através do Medline 
utilizando-se como parâmetro os seguintes termos: “cerebellum”, “cerebellar vermis”, “schizophrenia”, “bipolar disorder”, “depression”, 
“anxiety disorders”, “dementia” e “attention deficit hyperactivity disorder”. A busca eletrônica foi feita até abril de 2008. Discussão: 
Anormalidades cerebelares estruturais e funcionais têm sido relatadas em muitos transtornos psiquiátricos, entre eles a esquizofrenia, 
transtorno bipolar, transtorno depressivo, transtornos ansiosos, demências e transtorno de déficit de atenção e hiperatividade. Estudos 
utilizando imagem por ressonância magnética estrutural relataram a diminuição do volume total do cerebelo e do vermis cerebelar na 
esquizofrenia, transtornos do humor e transtorno de falta de atenção com hiperatividade. Estudos utilizando ressonância magnética 
funcional e paradigmas cognitivos têm demonstrado alterações na atividade cerebelar na esquizofrenia, transtornos ansiosos e transtorno 
de falta de atenção com hiperatividade. Nas demências, o cerebelo é afetado nos estágios mais avançados dessas doenças. Conclusão: 
Contrastando com as primeiras teorias, o cerebelo parece apresentar um papel mais importante em diferentes funções cerebrais além 
do controle motor e do equilíbrio, incluindo a regulação emocional e cognição. Futuros estudos são necessários para melhor elucidar o 
papel do cerebelo em ambos os comportamentos, normal e patológico, na regulação do humor e nas funções cognitivas.
Descritores: Cerebelo; Esquizofrenia; Transtornos do humor; Transtornos da ansiedade; Demência
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Introduction
For many years, functions related only to movement, gait, posture, 
and balance were attributed to the cerebellum. However, some 
studies have suggested a possible involvement of the cerebellum 
in cognition, emotion processing and behavior.1-8 From this 
perspective, the cerebellum would exert a regulatory function that 
would enhance and supplement other brain functions, throughout 
direct and indirect circuits.1,5,8
Moreover, different sources of evidence have suggested that the 
cerebellum may be altered in many psychiatric disorders, including 
schizophrenia, bipolar disorder, unipolar depression, anxiety, 
and attention deficit hyperactivity disorder.5,9 In some reports, 
cerebellar deficits were described as isolated findings, without 
relation with clinical history. But in others there is evidence that the 
cerebellum is a relevant brain structure possibly related to a range 
of psychopathological manifestations.9
This update article aims to report structural and functional brain 
imaging studies examining the cerebellum in psychiatric disorders 
and a possible role of cerebellum in their pathophysiological 
mechanisms. Finally, the implications of these findings and future 
directions are discussed.
The role of cerebellum
There is increasing evidence that the cerebellum is not only 
connected with motor pathways but also with other cortical 
and association areas involved in superior mental functions, 
suggesting the involvement of the cerebellum in cognition9 in the 
pathophysiology of psychiatric disorders.
In animal studies, axonal transport mechanisms have been 
used to document connectivity between the cerebral cortex and 
the brainstem and cerebellum. Cerebellum receives input from the 
spinal cord, vestibular nuclei, special relay nuclei of the brainstem 
(including the inferior olive and pontine nuclei), and, via these 
relay nuclei, from the cerebral cortex.10 Afferents from spinal cord 
and brain stem enter the cerebellum via the inferior cerebellar 
peduncle, whereas afferents from the cerebral cortex (relayed in 
the pontine nuclei) enter via middle cerebellar peduncle. Those 
peripheral pathways are related to proprioception, motor, gait and 
posture processing.
In order to appreciate the involvement of the cerebellum in 
cognition and psychopathological symptoms, it is important to 
understand its afferent and efferent connections. The cortico-ponto-
cerebellar pathway is the most important of the central afferent 
circuits originated from motor and sensitive cortical areas. After 
connecting with pontine nuclei, the pontocerebellar tracts connect 
with contralateral cerebellar hemisphere in a somatotopic way. 
The other cerebellar peripheral pathways originate from brainstem: 
the olivocerebellar tract with fibers originating from the inferior 
olive that receives excitatory impulses from the red nucleus, basal 
ganglia, reticular formation, and spinal cord (spinal-olivar); the 
vestibulocerebellar tract with fibers originating from the vestibular 
nuclei and projects to the fastigial and flocculonodular nuclei; and 
the reticulocerebellar tract with fibers originating from the reticular 
formation and projects to the cerebellar vermis.
The main outputs of the cerebellum are to the brainstem and 
to the cerebral motor cortex (via the red nucleus and ventrolateral 
nucleus of the thalamus). There are three main cerebellar efferent 
pathways:
1) Fibers that originate in the cerebellar vermis projecting to the 
fastigial nucleus and then to the pons, medulla oblongata, and 
reticular formation;
2) Fibers that originate in the intermediate zone of the cerebellar 
hemisphere projecting to the interpositus nucleus and then to 
the red nucleus and thalamus (ventrolateral and ventroposterior 
nucleus). After connecting to the thalamus, those fibers connect to 
the rubrospinal pathway and basal ganglia;
3) Fibers that originate in the lateral zone of cerebellar hemisphere 
and project to the dentate nucleus, and then to thalamus. After the 
thalamic connection, those fibers are projected to the cerebral cortex 
(posterior parietal, superior temporal, prefrontal), reticular formation, 
and then to the corticospinal and reticulospinal pathways.
The cerebellar nuclei projects to the caudal ventrolateral 
contralateral thalamic nuclei and then to the frontal motor cortex. 
Cerebellar nuclei may also connect with the intralaminar and motor 
thalamic nuclei and then project to association and limbic cortices 
(cingulate and parahippocampal gyri). 
Many studies have also demonstrated crossed connections 
between the dentate nucleus and the dorsolateral prefrontal cortex 
in the cerebellum-thalamic-cortical direction. The same crossed 
pattern was observed for specific areas of the inferior posterior 
parietal cortex.9,11,12 Through these extensive interconnections, with 
afferent (cortico-ponto-cerebellar) and efferent (cerebello-thalamo-
cortical) pathways, the cerebellum can receive information, as well 
as influence cortical cerebral areas related  to cognition.9
Significant interconnections between the cerebellum and 
prefrontal cortex subdivisions related to executive functioning 
(working memory, attention, inhibition of behaviors, and decision 
making), verbal memory and language have been demonstrated.13 
Afferent projections from parietal, temporal, and occipital cortices, 
and limbic system  implicated in the integration of sensitive and 
sensorial information, visuospatial organization, visual memory, and 
control of behavior and motivation have also been proposed.14,15
More recently, a timekeeping or “clock” function has been 
postulated for the cerebellar cortex and the inferior olive (the sole 
source of climbing fiber inputs to Purkinje cells) based on their unique 
microstructure and intrinsic rhythmic oscillatory properties.16,17 Xu 
et al. proposed that the primary role of the inferior olive and the 
climbing fiber system in timing is to mediate the encoding of 
temporal information independent of motor behavior.18
Cerebellum and psychiatric disorders
1. Schizophrenia
Schizophrenia is a severe and highly heritable psychiatric disorder 
that has been linked to multiple genes and neurodevelopmental 
factors, with a lifetime prevalence of about 1% in general 
population. Symptoms usually begin in late adolescence or early 
adulthood.19,20
The clinical manifestations are variable, including perceptual 
alterations (hallucinations), form and content of thought (incoherent 
thought or with loosening of associations, delusion), disorganized 
speech, grossly disorganized or catatonic behavior, and “negative” 
symptoms (alogia, affective flattening, avolition, social isolation). 
Cognitive impairments mainly affecting intelligence, memory, 
language, executive functioning, and attention domains are also 
common.20,21
Over the past three decades, neurophysiological studies using 
different models for schizophrenia have identified several brain 
alterations. There are global impairments in cognition with altered 
executive functions (action planning, inhibition, cognitive flexibility 
monitoring, abstract reasoning), memory (difficulties in the semantic 
organization of the content of the memory and overcoat in verbal 
memory and visuospatial tasks), attention (difficulties intrusions 
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control, in the divided  and sustained attention, focus changing) and 
language (fluency but without alterations in vocabulary).1,9,18 
There is evidence that patients with schizophrenia have altered 
corticocerebellar connectivity.18 Andreasen et al. proposed that 
disruption of the cortical-thalamic-cerebellar-cortical circuit 
(CTCC) may underlie at least part of symptomatology observed in 
schizophrenia.18,22 Analogous to the cerebellar role in facilitating 
rapid and smooth execution of motor tasks, these authors further 
proposed that the CTCC performs a similar role in  monitoring and 
coordinating the execution of mental activity resulting in normal 
cognitive functioning.18,23
Neuroanatomical, neuropathological, and brain imaging studies 
have consistently described enlargement of the cerebral ventricles, 
reduction in total cerebral volume, structural and functional 
alterations in frontal and temporal lobe structures, limbic system, 
thalamus and basal ganglia.9 Neurostructural studies have revealed 
smaller total cerebellar volume, smaller vermis volume, reduction 
of hemispheric asymmetry, while functional neuroimaging studies 
using cognitive paradigms have demonstrated frontal-thalamic-
cerebellar hypoactivity in schizophrenia.23
Magnetic resonance imaging (MRI) analyses using quantitative 
anthropometric techniques have yielded more consistent reports 
of cerebellar atrophy in schizophrenia,22,24 with some authors 
attempting to delineate a subset of patients with reduced or atrophied 
cerebellum. Global reduction of cerebellum in patients with 
schizophrenia seems to be associated in some cases with perinatal 
brain insults,25 in others with male gender,26 childhood-onset,27 very-
late-onset,28 chronic course,29 and positive psychotic symptoms.30 
Other authors have noted atrophy limited  to the vermis.22,26
In some diseases, cerebellar hemispheres may be reduced 
secondary to the contralateral atrophied cerebral hemisphere. This 
condition is called diaschisis. There are studies in schizophrenia 
suggesting that cerebellar volume reduction is not only a consequence 
of superior structures atrophy. Unaffected first-degree relatives of 
probands with schizophrenia and neuroleptic naïve patients with 
schizophrenia have also presented reduced cerebellar volumes. 
These data suggest that cerebellar atrophy may be a heritable trait 
rather than a treatment associated epiphenomenon.18,22
Studies of schizophrenia using the tools of functional imaging 
from our own group have found a relatively consistent pattern 
of abnormalities in distributed brain regions that include the 
cerebellum.1,31-33 Abnormalities are seen in these studies in both 
the vermis and the cerebral hemispheres in patterns that are task-
related. Patients with schizophrenia have decreased blood flow in the 
cerebellum in a broad range of tasks that tap into diverse functional 
systems of the brain, including memory, attention, social cognition, 
and emotion.31-33 Vermal abnormalities are more frequently noted 
in tasks that use limbic regions (e.g., studies of emotion), whereas 
more lateral neocerebellar regions are abnormal in tasks that use 
neocortical regions (e.g., memory encoding and retrieval).1,32
Soft neurological signs suggestive of cerebellar dysfunction, such 
as subtle ataxia, difficulties in coordination, dysdiadochokinesia, 
intentional tremor, dysmetria of the ocular saccadic movements 
are frequent in patients with schizophrenia.9 Additionally, 
emergence of positive symptomatology (especially delusions), as 
well as cognitive deficits (e.g., difficulties in synthesis and logical 
sequencing and verbal fluency) and negative symptomatology, 
including flattened affect, thought disorder, avolition, social 
isolation, and poor speech, have frequently been reported in 
individuals with cerebellar lesions.9,34,35
There are not studies that support the idea that cerebellum may 
be involved in motor disturbances in patients with schizophrenia 
using neuroleptics. Only one study found evidence of reduction 
in metabolic activity in the cerebellum of patients with akathisia 
using olanzapine.36 This theory is difficult to prove mainly because 
in structural studies movement disorders are used as exclusion 
criteria and in functional studies cerebellum is used as parameter 
of normality in image analysis. 
Converging evidence from neuroimaging and cognitive studies 
suggests cerebellar abnormalities in schizophrenia, which could 
account for some of the positive, negative, and cognitive symptoms 
present in this disease. Up to now, there are no studies showing 
if treatment has an impact on cerebellar functioning or if the 
cerebellar abnormalities are related to course or prognosis. There 
are also few studies exploring changes in cerebellar functioning 
after neuropsychological rehabilitation.
2. Bipolar disorder
Bipolar disorder is a chronic and generally life-long condition 
affecting about 1.6% of the population. It is characterized by 
unusual shifts in mood state, energy level, and behavior. These 
dramatic fluctuations may alternate between depression, normal 
mood, and elation and/or irritability.37,38 In spite of the progresses 
of the research methods in biological psychiatry and of the current 
knowledge on the mechanisms of action of the mood stabilizers, the 
pathophysiology of bipolar disorder is still poorly understood.
Several case reports have demonstrated cerebellar atrophy in 
patients with mood disturbances, as well as in patients with bipolar 
disorder.39-41 Moreover, some studies have found abnormal cerebellar 
anatomy in subjects with affective disorders.42 Two studies reported 
a greater rate of cerebellar atrophy in manic patients as compared 
to patients with schizophrenia or healthy controls.25 Additionally, 
Yates et al. found a greater rate of cerebellar atrophy in patients with 
bipolar disorder who were over 50 years old, but not in younger 
bipolar patients compared with healthy volunteers.43 Lippmann 
et al. found increased rates of both vermal atrophy and cerebellar 
hemisphere atrophy in bipolar patients with co-occurring alcohol 
abuse as compared with healthy volunteers, suggesting that alcohol 
abuse may contribute to abnormal cerebellar anatomy in bipolar 
patients.44 Surprisingly, this potential confounder is rarely observed 
in most of the studies and may be alone responsible for cerebellar 
atrophy. On the other hand, one study using multiple regression 
analysis excluded alcohol use as a potential confounder for vermal 
area atrophy volume in patients with bipolar disorder.45
Vermal subregion V2 volume was significantly smaller in 
multiple-episode bipolar disorder subjects than in first-episode 
patients and healthy subjects, while vermal subregion V3 was 
significantly smaller in multiple-episode bipolar disorder subjects 
in comparison with healthy subjects. Taken together, these results 
suggest that posterior-inferior cerebellar vermal abnormalities are 
present in patients with multiple-episode bipolar disorder.46 A 
subsequent MRI investigation of the cerebellum in patients with 
bipolar disorder did not reveal any gross morphological differences 
between patients and healthy controls. However, when patients 
with bipolar disorder were subdivided into first-manic-episode and 
multiple manic-episode groups, the V3 subregion was significantly 
smaller in the multiple-episode group.46,47
Further analysis revealed that, among multiple-episode patients, 
the number of previous depressive episodes, but not substance 
abuse or duration of lithium exposure, contributed to the reduction 
in V3 volume. Loeber et al. employed dynamic susceptibility 
contrast MRI and reported that patients with bipolar disorder had 
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lower cerebellar regional cerebral blood flow (rCBF) than healthy 
controls and patients with schizophrenia, even after controlling 
for volume differences.48 The cerebellar region most frequently 
reported in neuroimaging studies involving bipolar patients, the 
vermis, showed the largest reduction in rCBF. After treatment with 
atypical antipsychotic drugs, however, this relative decrease in 
rCBF disappeared.47
Preliminary in vivo studies have shown structural and functional 
abnormalities in bipolar patients compared with healthy control 
subjects. Smaller cerebellar volume with decreased blood or 
increased glucose metabolism is the main finding in bipolar patients. 
Although controversial, the functional findings may reflect the clinical 
heterogeneity of the bipolar populations studied. Thus, it is possible 
that cerebellar hypermetabolism is a finding restricted to treatment 
resistant bipolar subjects.47 Finally, there is no evidence yet whether 
these findings are cause or consequence of the disease.
3. Unipolar depression
Depression is a mood disorder characterized by psychic, physical, 
cognitive, physiological, and behavioral alterations. A variety of 
pathophysiological mechanisms have been proposed to explain 
this disorder, including genetic alterations, monoamine system 
dysfunction, and downregulation of neuroreceptors, among others. 
Structural and functional abnormalities in the prefrontal cortex, 
limbic system, and basal ganglia have consistently been described 
in patients with major depression.9,18
Using a PET analysis of regional blood flow, Reiman et al. 
investigated the neurofunctional correlates of externally generated 
emotions.49 These authors scanned healthy volunteers as they 
watched movies designed to evoke a variety of emotional states, 
including happiness, sadness, and disgust. In addition to the 
activation of limbic and paralimbic areas, it was observed an 
activation of cerebellar hemispheres. Using a similar paradigm, Lane 
et al. extended these results by demonstrating that sadness, but not 
happiness, increased activity in the anterior cerebellar vermis.50
In another PET investigation, rCBF was compared in subjects 
with acute depression and healthy controls before and after a 
transient mood challenge. In agreement with the results obtained 
with fMRI, patients with depression displayed lower rCBF in 
cerebellum and thalamus.51 Dolan et al. were the first to report 
an increase in baseline cerebellar vermal blood flow in a subset 
of patients with depression and cognitive impairment.47,52 More 
recent data suggest that this tonic increase in cerebellar activity 
is characteristic of major depression, regardless of mood state or 
medication exposure.47
More recently, MRI studies have shown reduced cerebellar volume 
in patients with unipolar depression. There are data suggesting 
that cerebellar atrophy is related to severity and nonresponse to 
antidepressant treatment.53 A recent MRI investigation revealed 
a negative correlation between total cerebellar tissue volume and 
baseline depression scores. In the same study, cognitive deficits in 
depressed patients were related to lower cerebellar cortex activity 
in PET analyses.53
There is emerging evidence suggesting that the cerebellum is 
involved in identification and expression of emotions.5,9 Expression 
of emotions, mainly sadness, seems to be impaired in both severe 
and resistant depression. Some studies hypothesize that impairment 
in emotion expression might be, in part, due to a disruption in the 
functional connection between the cerebellum and frontal lobe.5,54,55 
But there are not data showing if these alterations are a risk factor 
for developing depression or if they are already present before the 
disease onset, or even a consequence of the disease. Future cohort 
studies as well as studies with relatives of depressed patients are 
warranted to address these questions.
4. Anxiety disorders
Anxiety is a normal reaction to stress and, if not excessive, is 
crucial for homeostasis. Prolonged or excessive anxiety states, 
however, may be associated with brain damage, possibly mediated 
by a hyperactive hypothalamus-pituitary-adrenal (HPA) axis. 
Anxiety disorders represent a heterogeneous group of diseases 
that share pathological anxiety as a core symptom.56 Although 
pathophysiology of anxiety disorders is still unclear, possible 
mechanisms affecting regional cerebral blood flow (reduction 
in frontal, parietal, temporal and cingulate areas), metabolism 
(frontal, temporal, parietal, cerebellum, thalamus, limbic system 
and basal ganglia), neurotransmission (GABA, norepinephrine, 
and serotonin system), and neuroendocrine system have been 
proposed.56
Cerebellum might play a role in anxiety manifestations like 
hyperarousal symptoms, which are present in different disorders 
such as posttraumatic stress disorder (PTSD) and generalized anxiety 
disorder (GAD).57 Recent evidence suggests that cerebellum may 
be involved in PTSD pathophysiology. De Bellis and Kuchibhatla 
reported a smaller cerebellar volume (both hemispheres) in children 
with PTSD secondary to maltreatment.58 Moreover, in a case report, 
increased cerebellum, precuneus and supplementary motor cortex 
activation was observed in response to traumatic reminders.59 
This hyperactivity disappeared upon successful treatment with 
fluoxetine. A bilateral increase in resting cerebellum perfusion 
ratio on hexamethylpropyleneamineoxime single photon emission 
computed tomography (SPECT) was found in adult subjects with 
recent-onset PTSD compared with both trauma exposed subjects 
without PTSD and non-exposed subjects.60 In the subgroup of 
subjects with comorbid borderline personality disorder and PTSD 
examined with functional magnetic resonance (fMRI), there was 
a hyperactivity in anterior temporal lobes, mesiotemporal areas, 
amygdala, posterior cingulate, occipital areas, and cerebellum in 
response to traumatic reminders.61
Results from studies involving combat-related PTSD subjects 
suggest an increased sensitivity of the sympathetic nervous 
system that is more evident under experimental conditions 
of stress or challenge.58 In addition, cerebellar vermis activity 
is increased during biofeedback relaxation.62 Moreover, left 
cerebellar hemisphere is activated during discrete sympathetic 
skin conductance responses.63 In a PET study, mean arterial blood 
pressure and heart rate correlated with cerebellar hemisphere 
and vermis activity while subjects were performing isometric 
exercise and mental arithmetic stressor tasks,64 suggested a role 
of cerebellum in sympathetic regulation.
A PET study reported that social anxiety induced by the mental 
arithmetic task was associated with activation of cerebellum and 
other areas such as prefrontal cortex, thalamus, insula, and ventral 
striatum.65 In another PET study, panic disorder patients showed 
appreciably high anxiety before scanning and exhibited significantly 
higher levels of glucose metabolism in the bilateral amygdala, 
hippocampus, thalamus, midbrain, caudal pons, medulla, and 
cerebellum as compared to controls.66
The cerebellum seems to be reduced in its volume but more 
activated in some tasks in patients with anxiety disorders. Studies 
exploring the clinical implications of the cerebellum hyperactivity 
in anxiety disorders are still lacking.
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5. Neurodegenerative dementias
Dementias constitute a heterogeneous group that share cognitive 
impairment of organic etiology. Although several causes and 
pathophysiological mechanisms underlie clinical presentation of 
different types of dementia, neuroimaging studies have confirmed 
some common findings such as atrophy of certain brain structures 
or even global brain atrophy and progressive impairment of different 
cognitive domains.67 
Cerebellar volume seems to be reduced in patients with dementia. 
The most frequent hypothesis is related to diaschisis. Other 
hypothesis is that the cerebellar atrophy is due to vascular factors, 
molecular factors (dementia pathophysiological mechanisms directly 
affecting cerebellum) or by toxins (e.g., alcoholic dementia).36 
However, these alterations are only observed in the late stages of 
disease in the majority of studies.68,69
In Alzheimer’s disease (AD), cerebral structures interconnected 
with cerebellum are affected by neurofibrillary tangles and neuronal 
loss in later stages of the disease. Hypothetically, atrophic changes 
in cerebral structures might underlie atrophic changes in the 
cerebellum.68 A classical major neuropathological change in AD is 
represented by deposits of beta-amyloid plaques and neurofibrillary 
tangles in neocortical and subcortical regions, but these pathological 
processes are not present in the cerebellum.68 Thus, cerebellum 
is a unique structure in terms of AD pathologic manifestations. 
There is a strong correlation between the loss of granule cells and 
duration of AD. Additionally, although cerebellum is virtually free 
of neurofibrillary pathology, the magnitude of cerebellar atrophy 
strongly correlates with duration and stage of illness.68 In most of 
the of studies, cerebellum atrophy is evident only in late stages 
of disease.68-72
The climbing fibers originating from the inferior olivary nucleus 
act as a powerful excitatory pathway on the Purkinje cells of 
the cerebellar cortex that may play a substantial role in motor 
performances and learning of new motor skills. In vascular dementia, 
the existent vascular alterations may induce many hypoxic or 
ischemic phenomena, among others, in the olivocerebellar system 
affecting the climbing fibers in their way to the molecular layer of 
cerebellar cortex.73 Consequently, these alterations may be related 
at least partly to some symptoms in these patients.
In autopsy cases of vascular dementia, the application of silver 
impregnation technique and electron microscopy revealed a substantial 
decrease in the number of climbing fibers in the cortex of vermis, 
flocculus, and cerebellar hemispheres.73 The presynaptic varicosities 
and the synaptic terminals of climbing fibers on the Purkinje cell 
dendrites were decreased in number and were characterized by a 
marked poverty of synaptic vesicles.73 The synaptic cleft was mostly 
abnormal and wider than 20 nm. Mitochondrial abnormalities such 
as elongated mitochondria with disruption of the crystal were seen 
in terminal branches of climbing fibers arborization as well as in 
presynaptic components. The blood capillaries demonstrated a 
considerable thickness of the basal membrane and perivascular 
astrocytic proliferation, whereas the tight junctions between the 
endothelial cells were ultrastructurally intact.73
In summary, cerebellum appears to be affected in later stages 
of dementia, probably due to the atrophy of superior structures 
and spreading of disease. To our knowledge, there are no studies 
examining the relationship between cerebellum volume and 
prognosis in different types of dementia. Since dementia prognosis 
is strongly associated with performance on daily activities, which, 
in turn, are related to motor functions, one might speculate that 
cerebellum insult may negatively correlate with prognosis.
6. Attention deficit hyperactivity disorder 
Attention deficit hyperactivity disorder (ADHD) is present in about 
of 5% of population in school period and about 30 a 50% of these 
cases can still be symptomatic in adult age.9 In ADHD, three groups 
of main symptoms are: attention deficit (distractibility, difficulty with 
concentration and focus), impulsiveness (impatience, difficulty in 
postponing answers and rewards, negligence, impetuosity) and 
hyperactivity (excessive locomotor activity, restlessness, inadequate 
motive agitation).74
Dysfunct ion of  noradrenergic and/or dopaminergic 
neurotransmission has been widely implicated in the manifestation 
of ADHD.75 On the other hand, some theories about ADHD focus 
on frontal-subcortical functional disturbance, while structural and 
functional neuroimaging studies show alterations in prefrontal 
cortex, cingulum, basal ganglia, corpus callosum and cerebral 
total volume.9
Valera et al. conducted the first meta-analysis of structural 
neuroimaging findings in children and adolescents with ADHD. This 
meta-analysis found global reductions in brain volume, with most 
prominent reductions affecting total and right cerebral volumes, 
cerebellar regions, the splenium of the corpus callosum, and the 
right caudate nucleus.76 
Relatively little is known about how brain abnormalities in ADHD 
change over the life span. In a study by Castellanos et al., children 
and adolescents with ADHD were followed over time using MRI. 
Volumetric abnormalities in the cerebrum and cerebellum persisted 
with increasing age, whereas caudate differences versus control 
subjects disappeared. These findings appeared to be unrelated to 
stimulant treatment. Few structural neuroimaging studies have been 
conducted in adults with ADHD, which hampers our understanding 
of developmental trajectories.77 Seidman et al. previously reported 
volumetric reductions in frontal and anterior cingulate cortices in 
adults with ADHD.78
The association of ADHD with cerebellum alterations has been 
explored in the last 10 years. Some studies have shown smaller 
cerebellar volume in ADHD patients in comparison with normal 
controls.79,80 These findings are more specific in post-inferior 
cerebellar hemispheres and vermis.81,82 A negative correlation 
between the cerebellar volume and attention tests has also been 
reported.9,83 A functional study have demonstrated reduction in the 
activity of cerebellum and vermis.83
On the other hand, there are studies showing cognitive and 
behavior alterations similar of ADHD in patients with posterior 
cerebellar lesions, e.g., difficulties in the administration of the 
time, difficulties in sustaining attention, difficulties in dealing 
with abstract concepts, impulsivity, difficulties in production and 
organization.9,83
In summary, advances in neuroimaging research have helped 
to elucidate the neurobiology of ADHD. There is evidence of a 
noradrenergic and/or dopaminergic dysregulation, as well as 
structural brain and cerebellar abnormalities as likely contributing 
to the pathophysiology of ADHD. 
Conclusion and perspectives
Cerebellum makes an important contribution to the control 
of voluntary movement and movement coordination, as well as 
control of balance, gait, and posture. There is also strong evidence 
for a cerebellar role in cognition (memory, attention, language and 
executive functions), emotions, and anxiety. Cerebellum seems 
to work as an ”internal clock”, which comes into play during the 
control of movement, as well as during perceptual processing. 
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The exact nature of the cerebellar involvement in cognitive 
processes is so far less well understood. Functional and structural 
neuroimaging techniques also provide a valuable tool to study 
cerebellar contribution to different cognitive abilities and its role 
in psychiatric disorders. Abnormalities in cerebellar structure and 
function have been reported in some psychiatric disorders. Moreover, 
pharmacological and psychosocial therapeutic interventions for 
patients with those disorders have been associated with changes 
in cerebellar function, suggesting an important role of cerebellum in 
different mental processes, which are disturbed in some psychiatric 
disorders. Future studies examining cerebellum functions in patients 
with psychiatric disorders may extend the current knowledge on this 
issue. Another perspective is identifying different groups in the same 
disorder based on differences in cerebellum activation during the 
same task, as it has been described in bipolar disorder. Analyses 
of convergent data from genetic, neuropsychological, and structural 
and functional brain imaging studies could provide a unique 
opportunity to explore the role of cerebellum in pathophysiology of 
psychiatric disorders.
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